PROSPECTS AND OPPORTUNITIES
Generics and topical analgesics with a natural positioning drive growth
Analgesics in Guatemala is evolving and over the forecast period, there will be strong momentum across generics, topical analgesics, and targeted formulations. Generic analgesics will continue to expand their presence as consumers increasingly prioritise affordability amid rising unit prices.
Guatemala strengthens its role as a regional hub for generic pharma innovation and distribution
Guatemala has positioned itself as a strategic hub for pharmaceutical innovation and distribution in Central America. In particular the launch of Eurofarma’s generic brand, Genfar, which it acquired from Sanofi in 2023, and which is now Eurofarma’s brand of generics for all Latin American countries, has further cemented Guatemala’s position as a regional hub.
Increasing focus on a greener approach
Responding to global pressure to reduce plastic waste, Guatemala’s pharmaceutical sector will increasingly prioritise recycling, including more eco-friendly packaging solutions. In recent years, there has been a notable increase in recycling of medication containers and packaging.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Guatemala with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Guatemala, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Guatemala report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Guatemala?
- Which are the leading brands in Analgesics in Guatemala?
- How are products distributed in Analgesics in Guatemala?
- How has the regulatory and operating environment for Analgesics changed in Guatemala?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Guatemala - Category analysis
KEY DATA FINDINGS
Acetaminophen benefits from dengue outbreaks
Bayer continues to lead, but loses value share
Small local grocers dominate distribution
Generics and topical analgesics with a natural positioning drive growth
Guatemala strengthens its role as a regional hub for generic pharma innovation and distribution
Increasing focus on a greener approach
Consumer Health in Guatemala - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!